Richard J. Rodgers

Filings by Richard J. Rodgers span 3 companies, the busiest being Opus Genetics, Inc., Ardelyx, Inc. and Novavax Inc. In total, 25 filings cover trades dated from 16 June 2021 to 16 June 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 18 June 2026, the filings show a share grant in Ardelyx, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.